Evidence map›Paper›PMID 36986826›Full record

ArticlePharmaceutics2023

Radiothermal Emission of Nanoparticles with a Complex Shape as a Tool for the Quality Control of Pharmaceuticals Containing Biologically Active Nanoparticles.

Anton V Syroeshkin, Gleb V Petrov, Viktor V Taranov, Tatiana V Pleteneva, Alena M Koldina, Ivan A Gaydashev, Ekaterina S Kolyabina, Daria A Galkina, Ekaterina V Sorokina, Elena V Uspenskaya and 8 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Anton V SyroeshkinDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Gleb V PetrovDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Viktor V TaranovDepartment of Environmental Instrumentation, National Technical University of Ukraine "Igor Sikorsky Kyiv Polytechnic Institute", 37, Prosp. Peremohy, 03056 Kyiv, Ukraine.
Tatiana V PletenevaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.ORCID 0000-0001-7297-980X
Alena M KoldinaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.ORCID 0000-0001-8362-2363
Ivan A GaydashevDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Ekaterina S KolyabinaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Daria A GalkinaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Ekaterina V SorokinaI.I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia.
Elena V UspenskayaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.ORCID 0000-0003-2147-8348
Ilaha V KazimovaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Mariya A MorozovaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.ORCID 0000-0003-1586-2183
Varvara V LebedevaFederal Government Budgetary Institution "National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya St., 123098 Moscow, Russia.ORCID 0000-0002-3088-0403
Stanislav A CherepushkinFederal Government Budgetary Institution "National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya St., 123098 Moscow, Russia.ORCID 0000-0002-1734-5369
Irina V TarabrinaDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.ORCID 0000-0001-6582-8341
Sergey A SyroeshkinDepartment of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.
Alexander V TertyshnikovE. K. Fedorov Institute of Applied Geophysics, 129128 Moscow, Russia.
Tatiana V GrebennikovaFederal Government Budgetary Institution "National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya St., 123098 Moscow, Russia.ORCID 0000-0002-6141-9361
Peoples' Friendship University of Russia · RUMinistry of Health of the Russian Federation · RUInstitute of Applied Geophysics of the Academy of Sciences · RUNational Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute” · UAResearch Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has recently been shown that the titer of the SARS-CoV-2 virus decreases in a cell culture when the cell suspension is irradiated with electromagnetic waves at a frequency of 95 GHz. We assumed that a frequency range in the gigahertz and sub-terahertz ranges was one of the key aspects in the "tuning" of flickering dipoles in the dispersion interaction process of the surfaces of supramolecular structures. To verify this assumption, the intrinsic thermal radio emission in the gigahertz range of the following nanoparticles was studied: virus-like particles (VLP) of SARS-CoV-2 and rotavirus A, monoclonal antibodies to various RBD epitopes of SARS-CoV-2, interferon-α, antibodies to interferon-γ, humic-fulvic acids, and silver proteinate. At 37 °C or when activated by light with λ = 412 nm, these particles all demonstrated an increased (by two orders of magnitude compared to the background) level of electromagnetic radiation in the microwave range. The thermal radio emission flux density specifically depended on the type of nanoparticles, their concentration, and the method of their activation. The thermal radio emission flux density was capable of reaching 20 μW/(m

Indexed as

drug quality controlnanoparticlessupramolecular structuresthermal radio emission

Identifiers

PMID36986826
PMCPMC10059067
OpenAlexW4327739790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.